FindTrial
Sign In

Nasopharyngeal Airway for short general anesthesia

Efficacy of Nasopharyngeal airway as a conduit in general anesthesia with spontaneous respiration - clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045160
Enrollment
70
Registered
2022-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Putting a nasopharyngeal airway for giving inhalation agents: Nasopharyngeal airway is commonly used in airway obstruction , here it is used to provide oxygen and inhalational agents Co

Sponsors

Dr Anuoama Sahasrabudhe
Lead Sponsor
Dr Rashmee chvan
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing short duration procedures under general anesthesia without need of intubation

Exclusion criteria

Exclusion criteria: ASA grade 3&4, MPC 4, BMI > 35, Known case of DNS, Patient on antiplatelet/anticoagulants , expexted surgical duration more than 30min

Design outcomes

Primary

MeasureTime frame
ventilation assessed by adequate chest movements, square wave form capnograpy with normal range of end-tidal CO2 30-45, minimal alveolar ventilation valve of 1, for every 5minTimepoint: 30 minutes—

Secondary

MeasureTime frame
to evaluate intra-opeartive hemodynamic stability/ depth of anesthesiaTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr ILA M S

Dr D Y Patil Medical college and Hospital

dranuds@gmail.com9822010603

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026